HomeACXP • NASDAQ
add
Acurx Pharmaceuticals Inc
Previous close
$6.50
Day range
$6.31 - $6.80
Year range
$3.80 - $39.20
Market cap
10.32M USD
Avg Volume
1.14M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.27M | -44.95% |
Net income | -2.25M | 45.50% |
Net profit margin | — | — |
Earnings per share | -1.89 | 63.65% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.06M | -4.66% |
Total assets | 6.16M | -6.42% |
Total liabilities | 2.59M | -17.81% |
Total equity | 3.57M | — |
Shares outstanding | 1.58M | — |
Price to book | 2.67 | — |
Return on assets | -103.51% | — |
Return on capital | -193.07% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.25M | 45.50% |
Cash from operations | -1.67M | 42.00% |
Cash from investing | — | — |
Cash from financing | 3.09M | 865.24% |
Net change in cash | 1.42M | 155.48% |
Free cash flow | -929.03K | 40.01% |
About
CEO
Founded
2017
Website
Employees
4
